Patents by Inventor Stanislas Pol

Stanislas Pol has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-HBV ANTIBODIES AND METHODS OF USE
    Publication number: 20230340081
    Abstract: The invention provides anti-S-HBs antibodies and methods of using the same.
    Type: Application
    Filed: June 8, 2021
    Publication date: October 26, 2023
    Inventors: Maryline BOURGINE, Maxime BERETTA, Hugo MOUQUET, Verena HEHLE, Stanislas POL, Hélène STRICK-MARCHAND, Malika AIT-GOUGHOULTE, Nadège PELLETIER, Jens FISCHER, Guy GEORGES, Tilman SCHLOTHAUER, Erwin VAN PUIJENBROEK, Wouter DRIESSEN
  • METHODS OF USING sIP-10, CD26 INHIBITORS AND CXCR3 LEVELS IN A SAMPLE TO ASSESS CLEARANCE OF INFECTION, RESPONSE TO INTERFERON THERAPY, AND TREATING CHRONIC INFECTIONS
    Publication number: 20120171158
    Abstract: The present invention relates to methods for the treatment of infection, a disease, or a condition using CD26 (DPIV) inhibitors. The present invention also relates to an antibody that binds to the IP-10 protein and a method of monitoring the necessity for administering a CD26 inhibitor to a patient, comprising evaluating a level of sIP-10, a activity of CD26, and/or a level of CXCR3 cells in a sample.
    Type: Application
    Filed: January 20, 2012
    Publication date: July 5, 2012
    Applicant: INSTITUT PASTEUR
    Inventors: Matthew Albert, Armanda Casrouge, Jeremie Decalf, Stanislas Pol, Arnaud Fontanet, Mostafa Mohamed
  • Method For Diagnosing Thrombophilia
    Publication number: 20120115171
    Abstract: The invention relates to a method for diagnosing thrombophilia in a subject suffering from HIV or from a systemic auto-immune disease, said method comprising determining in a blood sample obtained from said subject the level of free Protein S having Activated Protein C (APC) cofactor activity and the level of total Protein S.
    Type: Application
    Filed: May 7, 2010
    Publication date: May 10, 2012
    Applicants: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), ASSISTANCE PUBLIQUE HOPITAUX DE PARIS, UNIVERSITE RENE DESCARTES PARIS 5, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE-CNRS
    Inventors: Sebastien Lacroix-des-Mazes, Vincent Mallet, Srinivas Kaveri, Stanislas Pol
  • Methods of using sIP-10, CD26 inhibitors and CXCR3 levels in a sample to assess clearance of infection, response to interferon therapy, and treating chronic infections
    Patent number: 8124332
    Abstract: The present invention relates to methods for the treatment of infection, a disease, or a condition using CD26 (DPIV) inhibitors. The present invention also relates to an antibody that binds to the IP-10 protein and a method of monitoring the necessity for administering a CD26 inhibitor to a patient, comprising evaluating a level of sIP-10, a activity of CD26, and/or a level of CXCR3 cells in a sample.
    Type: Grant
    Filed: July 31, 2009
    Date of Patent: February 28, 2012
    Assignee: Institut Pasteur
    Inventors: Matthew Albert, Armanda Casrouge, Jeremie Decalf, Stanislas Pol, Arnaud Fontanet, Mostafa Mohamed
  • Methods of using sIP-10 to assess HCV clearance and/or response to interferon therapy
    Patent number: 7674578
    Abstract: The present invention relates to methods for evaluating and predicting clinical outcomes in patients by measuring levels of sIP-10 protein expression as well as therapies using sIP-10 and its fragments.
    Type: Grant
    Filed: September 14, 2007
    Date of Patent: March 9, 2010
    Assignee: Institut Pasteur
    Inventors: Matthew Albert, Jeremie Decalf, Stanislas Pol, Arnaud Fontanet, Mostafa Mohamed
  • METHODS OF USING sIP-10 TO ASSESS HCV CLEARANCE AND/OR RESPONSE TO INTERFERON THERAPY
    Publication number: 20080119388
    Abstract: The present invention relates to methods for evaluating and predicting clinical outcomes in patients by measuring levels of sIP-10 protein expression as well as therapies using sIP-10 and its fragments.
    Type: Application
    Filed: September 14, 2007
    Publication date: May 22, 2008
    Applicant: INSTITUT PASTEUR
    Inventors: Matthew Albert, Jeremie Decalf, Stanislas Pol, Arnaud Fontanet, Mostafa Mohamed